Allen H Unger, MD

Locations

Office

120 East 86th Street (bet Lex and Park), 2nd Floor, New York, NY, 10028

212-427-2000

Insurance Information

Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Publications

Scopus h-index:6

Article:6

Review Article:1

Recent Artifacts

• Pravastatin: An antithrombotic effect independent of the cholesterol-lowering effect
• Sex differences in lipid levels, thrombus formation, and response to pravastatin
• Gender differences in blood thrombogenicity in hyperlipidemic patients and response to pravastatin
• Pravastatin therapy in hyperlipidemia: Effects on thrombus formation and the systemic hemostatic profile
• The efficacy and safety of Pravastatin in patients aged 60 to 85 years with low-density lipoprotein cholesterol > 160 mg/dl
• Successful defibrillation with the use of left ventricular drainage after prolonged refractory ventricular fibrillation in experimental acute myocardial infarction
• Fatalities Following Intravenous Use of Sodium Diphenylhydantoin for Cardiac Arrhythmias: Report of Two Cases

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Unger has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.